Is There Any Future for Low-Molecular-Weight Heparin in the Prevention of Pregnancy Loss?

被引：2
|
作者：
Gris, Jean-Christophe [1 ]
机构：
[1] Univ Nimes Hosp, F-30006 Nimes, France
来源：
ANNALS OF INTERNAL MEDICINE | 2015年 / 162卷 / 09期
关键词：
RECURRENT MISCARRIAGE; WOMEN; MULTICENTER; ASPIRIN; TRIAL;
D O I：
10.7326/M15-0564
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：658 / 659
页数：2
相关论文
共 50 条
  • [21] A retrospective study on the use of low-molecular-weight heparin for prevention of pregnancy-related recurrent venous thromboembolism and obstetrical complications
    Abbattista, Maria
    Capecchi, Marco
    Gianniello, Francesca
    Artoni, Andrea
    Bucciarelli, Paolo
    Ciavarella, Alessandro
    Peyvandi, Flora
    Martinelli, Ida
    BLOOD COAGULATION & FIBRINOLYSIS, 2023, 34 (02) : 111 - 117
  • [22] Low-Molecular-Weight Heparin for the Treatment of Unexplained Recurrent Miscarriage With Negative Antiphospholipid Antibodies: A Randomized Controlled Trial
    Shaaban, Omar M.
    Abbas, Ahmed M.
    Zahran, Kamal M.
    Fathalla, Mohamed M.
    Anan, Mohamed A.
    Salman, Safwat A.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (06) : 567 - 572
  • [23] Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation
    Tormene, Daniela
    Grandone, Elvira
    De Stefano, Valerio
    Tosetto, Alberto
    Palareti, Gualtiero
    Margaglione, Maurizio
    Castaman, Giancarlo
    Rossi, Elena
    Ciminello, Angela
    Valdre, Leila
    Legnani, Cristina
    Tiscia, Giovanni Luca
    Bafunno, Valeria
    Carraro, Sara
    Rodeghiero, Francesco
    Simioni, Paolo
    THROMBOSIS AND HAEMOSTASIS, 2012, 107 (03) : 477 - 484
  • [24] Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis
    Chen, Jiahui
    Huai, Jing
    Yang, Huixia
    BMC PREGNANCY AND CHILDBIRTH, 2024, 24 (01)
  • [25] Low molecular weight heparin for pregnancy complications?
    Greer, I. A.
    THROMBOSIS RESEARCH, 2009, 123 : S22 - S25
  • [26] Anti-Xa Monitoring of Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review
    Kjaergaard, Amalie Baun
    Fuglsang, Jens
    Hvas, Anne-Mette
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2021, 47 (07) : 824 - 842
  • [27] Prolonged low-molecular-weight heparin use during pregnancy and subsequent bone mineral density
    Galambosi, Paivi
    Hiilesmaa, Vilho
    Ulander, Veli-Matti
    Laitinena, Leena
    Tiitinen, Aila
    Kaaja, Risto
    THROMBOSIS RESEARCH, 2016, 143 : 122 - 126
  • [28] Long-term Low-molecular-weight Heparin Therapy during Pregnancy: Is There a Bone Risk?
    Khalifa, Pierre
    Marie-Scemama, Lydia
    THERAPIE, 2013, 68 (01): : 37 - 42
  • [29] Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systematic review
    Mantha, S.
    Bauer, K. A.
    Zwicker, J. I.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (02) : 263 - 268
  • [30] Association between prophylactic low-molecular-weight heparin use in pregnancy and macrosomia: analysis of the Ottawa and Kingston birth cohort
    Lowry, D. E.
    Corsi, D. J.
    White, R. R.
    Guo, M.
    Lanes, A.
    Smith, G.
    Rodger, M.
    Wen, S. W.
    Walker, M.
    Gaudet, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (02) : 345 - 349
12345